What are the reversible causes of cardiomyopathy in infants?

Reversible Causes of Cardiomyopathy in Infants

The most critical reversible causes of cardiomyopathy in infants that must be identified immediately are: tachyarrhythmias (especially supraventricular tachycardia), anomalous left coronary artery from the pulmonary artery (ALCAPA), viral myocarditis, and metabolic/endocrine disorders including lysosomal storage diseases (Pompe disease) and congenital adrenal hyperplasia.

Primary Reversible Causes to Rule Out

1. Tachyarrhythmia-Induced Cardiomyopathy

• Heart rate >180 bpm in neonates/infants warrants immediate attention 1
• Supraventricular tachycardia is the most common arrhythmia causing this presentation 2
• Look for: persistent tachycardia that seems disproportionate to clinical state, irritability, feeding intolerance
• This is completely reversible with arrhythmia control - cardiac function normalizes after rate control 1, 2
• Obtain 12-lead ECG in ANY infant with new-onset heart failure 2

2. Anomalous Coronary Arteries (ALCAPA)

• ALCAPA is a surgical emergency - presents as dilated cardiomyopathy with severe LV dysfunction 3, 4
• Look for: signs of myocardial ischemia, mitral regurgitation, ECG changes suggesting anterolateral infarction
• Echocardiography may show turbulent flow at coronary origins 3
• Early surgical correction is life-saving and highly rewarding 4
• Cardiac catheterization provides definitive diagnosis when imaging is equivocal 3

3. Viral Myocarditis

• Most common viral causes: enteroviruses, adenoviruses, parvovirus B19 5
• Superior survival compared to idiopathic DCM - many children recover completely 5
• Clinical presentation: viral prodrome followed by respiratory symptoms (56%), decreased activity (17%), or nonspecific symptoms (14%) 6
• At least 66% recover, with only 24% progressing to death or transplant 6
• Consider myocarditis in ANY infant with viral prodrome plus tachycardia, hypotension, or rhythm abnormalities - even without cardiomegaly on chest x-ray 6

4. Lysosomal Storage Diseases

Pompe Disease (Glycogen Storage Disease Type II)

• Presents in infancy with cardiac involvement leading to death within first year if untreated 5
• Caused by α-1-4-glucosidase deficiency 5
• Higher incidence in blacks, southern Chinese, and Taiwanese 5
• Enzyme replacement therapy is available and life-saving

5. Metabolic and Endocrine Disorders

Congenital Adrenal Hyperplasia

• Glucocorticoid and mineralocorticoid deficiency can cause dilated cardiomyopathy 7
• Cardiomyopathy resolves completely with hormone replacement 7
• Consider in infants with unexplained cardiomyopathy, especially with electrolyte abnormalities or ambiguous genitalia

Nutritional Deficiencies

• Thiamine and carnitine deficiency can produce ventricular dilatation and dysfunction 4
• Particularly relevant in developing countries or specific dietary restrictions

6. Structural/Mechanical Causes

• Critical aortic stenosis 4
• Severe pulmonic stenosis 4
• Severe coarctation of aorta in infants 4
• These require urgent surgical intervention but are completely reversible with correction 4

7. Eosinophilic Myocarditis

• Secondary causes: drug allergy, vaccination, parasitic infection 5
• Diagnosis: eosinophils >1500/μL 5
• Treatment of offending agent can reverse the process 5
• Corticosteroid therapy is generally considered primary therapy 5

Critical Diagnostic Approach

Before labeling as "idiopathic DCM," systematically exclude:

1. 12-lead ECG - identify arrhythmias, conduction disease, ischemic changes 2
2. Comprehensive echocardiography - assess coronary origins, structural defects, wall motion abnormalities 6, 3
3. Metabolic screening - serum amino acids, acylcarnitine profile, lactate
4. Endocrine evaluation - cortisol, electrolytes, thyroid function
5. Viral studies - if myocarditis suspected: nasal swab, stool for viruses, blood PCR 5
6. Cardiac MRI - when diagnosis unclear or to characterize tissue (iron overload, fibrosis) 5
7. Genetic testing - particularly LMNA and SCN5A if conduction disease present 5

Key Clinical Pitfalls

• Do not miss tachycardia-induced cardiomyopathy - a heart rate that seems "normal" for an infant may still be pathologically elevated if persistent 1
• ALCAPA can be missed on routine echo - specifically interrogate coronary origins with color Doppler 3
• Myocarditis may present with minimal classical HF symptoms - maintain high suspicion with viral prodrome and any cardiac rhythm abnormality 6
• 87% of new-onset HF in children only reaches diagnosis when severely decompensated 6 - early recognition is critical
• In muscular dystrophies, HF symptoms may be concealed by reduced physical activity - requires proactive serial imaging 6

Prognostic Considerations

Younger age (<2 years) and presence of myocarditis offer better prognosis in DCM phenotype 5. This underscores the importance of identifying reversible causes, as these infants have the highest potential for complete recovery when the underlying cause is treated.

The distinction between reversible and irreversible causes directly impacts mortality - nearly half of children with symptomatic HF die or require transplant within 2 years 5, making early identification of treatable causes absolutely critical for survival.